Peer Review History
Original SubmissionAugust 29, 2023 |
---|
PONE-D-23-27788The effects of the COVID-19 pandemic period on stock market return and volatility. Evidence from the Pakistan Stock ExchangePLOS ONE Dear Dr. Waris, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The topic is interesting, but the authors need to address the reviewers concerns with the following comments:1. If COVID-19 has an impact globally on every economy, then why do you need to analyse the impact on the Pakistani economy?Explain the research gap in the introduction section.2. There are many other factors affecting the stock market during the analysis period; how did you statistically control these factors in your analysis?3. There are a lot of grammatical mistakes in the manuscript; English proofreading is required.4. The introduction needs to be revised properly according to your core idea.5. There is a lack of literature regarding the Pakistani economy and the COVID-19 pandemic. Include the following and other more updated literature on the Pakistani economy. DOI:10.3389/fpubh.2022.10554067. 6. The conclusion section must be separated and include policy implications, limitations, and the future of the study separately.. Be sure to: Please submit your revised manuscript by Nov 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Syed Usman Qadri, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: ABSTRACT To assess the impact on what? The author stated the objective which was to investigate………………. In the same abstract it was stated to assess the impact of what ?...............on what?..... Please complete the abstract with the impact you are determining. There are several grammatical errors in the abstract, please rewrite. For example ‘Our E-GARCH findings shows (show) that there is long-term persistent (persistence or persistent –‘…’) in the return volatility of the stock market of the Pakistan in the period of the COVID-19 timeline. The authors should be more elaborate in what the study advocated to the different stakeholders stated in the abstract because investors, policymakers, government, and regulators have different information need. INTRODUCTION The introduction has different styles of in-text referencing. The authors should stick to one or follow the journal’s requirement. There are several assertions without any sort of references therefore making it difficult to refer. The authors kept stating, ‘the study can’. The study is either investigating or not, it is not a conjecture. You are advised to use editing services or review appropriately. DATA ANALYSIS The WHO collects data from the National Health Services, what informs the use of WHO data than that of the Pakistani National Health Department? How does the WHO confirm the data? The authors can add those details to make a case for using WHO data than that from Pakistan Health Department. ‘The risk is measured through the dispersions in the return of the stock markets and fluctuate due to the daily cases of the pandemics (Andersen & Nielsen, 2011)’ The above statement and the reference present a fundamental error since COVID-19 started in 2020, and this is consistent in the study presenting a clear case of inappropriate referencing. What is the nature of the data collected from the WHO? In the objective, the authors stated ‘Investigate influence of daily COVID-19 cases on the volatility of the Pakistan stock market returns’ Therefore it is expected to see daily data multiplied by the period (duration) thus from March…….. Also this must be justified…… CONCLUSIONS What is the research impact? What are the research variables? Readers do not need to figure out the above items, it must be explicit and clear from the research objectives for consistency. Reviewer #2: Dear authors, Greetings and thank you for your efforts in preparing this paper. However, few comments can enhance it: 1- Authors should add recommendation/s to the abstract. 2- The introduction of your study is very clear and clearly expresses your study concerns. But your study introduction is really very long for a paper (5 pages) to understand the issue. Authors must give brief. This is not a book. 3- The aim of literature usually is to provide summary on where the previous studies have reached and then what is the justification of your study. However, very few studies in literature have been conducted during the pandemic period. Authors should focus on the studies conducted during the pandemic period and increase it as well. 4- Add sources to all tables and figures. 5- Authors should support their study findings with some previous studies results. This will enhance your results and therefore your study. 6- In page 23 you explained what some letters mean such as LR and HQ in the statistics. Authors should do the same for all the similar in the other tables in particular unknown letters. 7- References should be mainly from the last 5 years. too many references are very old. All the best, Reviewer #3: This study deals with a series of very important topics: The effects of the COVID-19 pandemic period on stock market return and volatility. Evidence from the Pakistan Stock Exchange. Unfortunately, the paper reveals several deficiencies requiring an in-depth review and major revision before submission. The following suggestions are provided below with the hope that the author will consider including them in future submissions. 1.The abstract should embody both clarity and conciseness. 2.The introduction of this article should provide a comprehensive assessment of the performance of the Pakistan Stock Exchange during the COVID-19 pandemic. It is imperative to include scholarly references alongside this review to maintain consistency between the declared study aims and the methodological framework utilized. The writers are expected to offer a comprehensive contextualization of the research and try to clarify how the publication's findings contribute to the current academic knowledge base, thereby improving our understanding of the subject matter significantly. 3.In the introduction section, the objective of the paper presented need more clarifications to suit reader to understand the main idea of the paper. 4.The literature review draws heavily on a few sources, which could mean that more research needs to be done. The credibility of the literature review would be improved by adding more current citations from different authors and publications. The literature review doesn't have any critical analysis or talk about the studies' strengths and flaws. If the existing literature's pros and cons were discussed, the study landscape would look more balanced. 5.Some of the paper needs to be include in the literature review. 1.Qadri, S. U., Raza, M., Qadri, S., Mahmood, S., Ye, C., Rauf, F., ... & Hossain, M. S. (2023). Overflow Effect of COVID-19 Pandemic on Stock Market Performance: A Study Based on Growing Economy. Discrete Dynamics in Nature and Society, 2023. 2.Aamir, M., Khan, N., Naeem, M., Bilal, M., Khan, F., & Abdullah, S. (2023). Implications of the COVID-19 pandemic on the shanghai, New York, and Pakistan stock exchanges. Heliyon, e17525. 3.Qadri, S., Chen, S., Qadri, S.U., Bukhari, W.N. (2023). Cultural Challenges in the Implementation of COVID-19 Public Health Measures. In: Yang, Z. (eds) Environmental Science and Technology: Sustainable Development. ICEST 2022. Environmental Science and Engineering. Springer, Cham. 6.The research method needs to Cleary justified. How the data sampling can be valid or justified? 7.You take data from March 15, 2020, to March 31, 2021; why not include more recent data to make your findings more comprehensive and general? 8.Why are you not including a discussion section? Add a section (Discussion) and compare your results to those of other studies. 9.In conclusion, while the article has its merits, certain aspects require refinement and expansion to ensure a clearer and more comprehensive presentation of the topic. 10.policy implications should be according to the results 11.Write properly study limitations and future direction. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
The effects of the COVID-19 pandemic period on stock market return and volatility. Evidence from the Pakistan Stock Exchange PONE-D-23-27788R1 Dear Dr. Waris, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Syed Usman Qadri, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Dear authors, It is immensely appreciated that each comment has been thoroughly addressed and taken into consideration. Wishing you all the best, Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: Yes: Dr.Shahid Mahmood ********** |
Formally Accepted |
PONE-D-23-27788R1 PLOS ONE Dear Dr. Waris, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Syed Usman Qadri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .